Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

UnavailableHealthcare: How Much Do Share Prices Matter In Big-Cap Biotech?
Currently unavailable

Healthcare: How Much Do Share Prices Matter In Big-Cap Biotech?

FromIndustry Focus


Currently unavailable

Healthcare: How Much Do Share Prices Matter In Big-Cap Biotech?

FromIndustry Focus

ratings:
Length:
18 minutes
Released:
Jul 6, 2016
Format:
Podcast episode

Description

We compare Biogen's and Celgene's current valuations and consider what might be in store for Gilead Sciences now that its new hepatitis C drug is approved.
Released:
Jul 6, 2016
Format:
Podcast episode

Titles in the series (100)

Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.